Pacific Biosciences of California, Inc. (PACB): Stock Offering News

PACB – Prices 12.5 mln share offering at $2.40/share.


Key Facts Surrounding This News Item


  • PACB had a POWR Rating of D (Sell) coming into today.
  • PACB was -4.26% below its 10-Day Moving Average coming into today.
  • PACB was -7.01% below its 20-Day Moving Average coming into today.
  • PACB was -7.67% below its 50-Day Moving Average coming into today.
  • PACB was -25.53% below its 100-Day Moving Average coming into today.
  • PACB was -30.94% below its 200-Day Moving Average coming into today.
  • PACB had returned -3.79% year-to-date leading up to today’s news, versus a -0.57% return from the benchmark S&P 500 during the same period.

More Info About Pacific Biosciences of California, Inc. (PACB)


Pacific Biosciences of California, Inc. designs, develops, manufactures, and markets an integrated platform for genetic analysis. The company was formerly known as Nanofluidics, Inc. The company was founded in 2000 and is based in Menlo Park, California. View our full PACB ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

PACB at a Glance

PACB Current POWR Rating™
Overall POWR Rating™
PACB Current Price $4.81 0.82%
More PACB Ratings, Data, and News

PACB Price Reaction

The day of this event (Feb. 13, 2018)
PACB Closing Price$2.47 2.76%
PACB Volume2,729,000
165.99% from avg
Leading up to this event
PACB 1-mo returnN/A%
After this event
PACB 1-day return2.83%
PACB 3-day return1.17%
PACB 5-day return0.78%

PACB Price Chart



More Pacific Biosciences of California, Inc. (PACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All PACB News
Page generated in 1.3263 seconds.